RelB is an unusual member of the Rel/NF-kB family of transcription factors which are involved in oncogenic processes. Due to a relaxed control by the IkBs, the cytosolic NF-kB inhibitors, RelB is constitutively expressed in the nuclei of lymphoid cells. We show here that RelB is inducibly degraded upon activation of T cells in a fashion similar to the IkBs. However, RelB degradation diers from that of IkBs since it is not induced by TNFa but only by T cell receptor or TPA/ ionomycin stimulation. Moreover, RelB degradation occurs in three steps: (i) after stimulation RelB is rapidly phosphorylated at amino acids Thr84 and Ser552 followed by (ii) an N-terminal cut and, ®nally, (iii) the complete degradation in the proteasomes. Since mutation of the two phosphoacceptor sites to non-acceptor sites abolished RelB phosphorylation in vivo and led to the stabilization of the mutated RelB DM , site-speci®c phosphorylation appears to be a necessary prerequisite for RelB degradation. RelB is a crucial regulator of NFkB-dependent gene expression. Thus, the signal-induced degradation of RelB should be an important control mechanism of NF-kB activity. Oncogene (2001) 20, 8142 ± 8147.
The Rel/NF-kB family of transcription factors plays a crucial role in many physiological and pathophysiological processes including oncogenesis (Gilmore et al., 1996; Neumann et al., 1997) . NF-kB is a dimer composed of the ®ve mammalian Rel proteins, p65/ RelA, c-Rel, p50/NF-kB1, p52/NF-kB2 and RelB, in almost any combination (Ghosh et al., 1998) . Among these Rel proteins, RelB displays a number of unusual features. It selectively forms complexes only with p50/ NF-kB1 and p52/NF-kB2 (Dobrzanski et al., 1994) and is constitutively found in the nucleus of unstimulated lymphoid cells (Lernbecher et al., 1993; Weih et al., 1994) indicating a relaxed control by the cytosolic IkB inhibitors.
In resting unstimulated cells, NF-kB is complexed with IkBs (Baldwin, 1996) . This interaction masks the nuclear localization signal of NF-kB and leads to its retention in the cytoplasm. As demonstrated for IkBa, the IkBs are inducibly phosphorylated at two Nterminal amino acids after stimulation by various agents (Brown et al., 1995; Chen et al., 1995; DiDonato et al., 1996) . Phosphorylation at these sites is mediated by a large multi-protein complex, designated as signalosome. A family of serine/threonineprotein kinases, the IkB kinases (IKKs), are responsible for N-terminal site-speci®c IkB phosphorylation (Karin and Ben-Neriah, 2000) which is a prerequisite for the subsequent ubiquitination and ®nal proteolytic degradation of IkBa in the proteasome (Chen et al., 1995; DiDonato et al., 1996; Karin and Ben-Neriah, 2000) . This results in the release and nuclear translocation of transcriptionally active NF-kB.
We observed that stimulation of T cells leads to a drastic decrease in cellular RelB concentration. This can be detected in numerous lymphoid cells (data not shown), but is seen best in human and murine primary T lymphocytes stimulated with TPA/ionomycin (T+I) ( Figure 1a ) and in Jurkat T cells stimulated with aCD3/CD28 or T+I (Figures 1b and 3b) after immunoblotting. Surprisingly, stimulation with TNFa, a strong inducer of IkB degradation, did not induce RelB degradation (Figure 1a,c) . In Jurkat cells RelB degradation reaches its maximum 30 ± 60 min after T+I stimulation and, therefore, is not as long-lasting as in primary T cells (Figure 1b) . It diers slightly from the kinetics of IkBa degradation which reaches its maximum 20 min after stimulation (Figure 1b) . Similar results were obtained in electrophoretic mobility shift assays (EMSAs) where two NF-kB complexes consisting of p50/p65 (complex I) and p50/RelB (complex II) were observed after TNFa stimulation of Jurkat cells for 1 and 4 h. In contrast, due to RelB degradation only complex I was detected in protein extracts from Jurkat cells induced for 1 h by T+I (Figure 1d) . A densitometrical analysis of a set of immunoblot experiments performed with Jurkat cell extracts and a subsequent statistical evaluation of the data revealed that, whereas both stimuli could induce IkBa degradation, only T+I (Figure 1e ), but not TNFa (Figure 1f ) led to a strong decrease in RelB expression to less than 40% of the expression level found in non-stimulated cells (Figure 1e ).
Similar to IkB proteolysis, RelB degradation might be due to signal-dependent phosphorylation. As seen in Figure 1b (middle row, compare lanes 1+2), stimulation of Jurkat cells rapidly led to a subtle decrease in mobility of the RelB band possibly indicative of RelB phosphorylation. This could be demonstrated best using murine EL-4 T cells whose stimulation led to the appearance of a second, slower migrating RelB band. This band was substantially decreased after dephosphorylation with shrimp alkaline phosphatase (SAP) (Figure 2a ). The incomplete reaction is likely due to the eciency of the and from murine lymph node (LN-Ts) and human peripheral blood T cells (PBL-Ts) stimulated with TPA (20 ng/ml) plus ionomycin (1 mM) (T+I), aCD3/CD28 (soluble UCHT; mouse IgG1; Immunokontact Frankfurt; Germany) or TNFa (40 U/ml; Sigma, St. Louis, MO, USA) (lanes 2 ± 5) using a RelB-speci®c antibody (Santa Cruz (SC), C19, #sc-226) were performed as described (Neumann et al., 1995) . (b) Immunoblots with antibodies speci®c for RelB or IkBa (SC; C-21, #sc-371) and nuclear and cytoplasmic protein extracts from uninduced or T+I-stimulated Jurkat cells. (c) Immunoblots performed with RelB-and IkBa-speci®c antibodies and protein extracts from TNFa-stimulated Jurkat cells. (d) EMSAs of nuclear proteins from uninduced Jurkat cells or cells stimulated with T+I or TNFa using a kB-site from the c-myb intronic enhancer as probe which favors RelB binding (Suhasini et al., 1997) were performed as described previously . In lane 6, control EMSA with an excess of unlabeled probe. In lanes 7 and 8 supershift EMSAs are shown performed with antibodies speci®c for RelB or RelA (SC; A, #sc-109). Arrows indicate the speci®c complexes I, II and III consisting of p50/p65 (I), p50/RelB (II) and p50/p50 complexes, or supershift signals, respectively. (e) Diagram of RelB expression in Jurkat cells stimulated with TPA/ionomycin for the indicated times. Immunoblots performed with whole cellular extracts of at least three independent experiments were densitometrically analysed. After normalization using b-actin expression, the average changes of RelB and IkBa expression in per cent of the expression in non-stimulated cells (100%) were determined. (f) Presentation of changes of RelB and IkBa expression after TNFa stimulation of Jurkat cells phosphatase at the concentration and incubation time used.
To show whether RelB was degraded in proteasomes, Jurkat cells were pretreated with the speci®c proteasome inhibitors MG115 and calpain inhibitor I before induction (Figure 2b, lanes 3 and 4) . Both agents led to a distinct reduction in RelB degradation at a concentration of 10 mM which speci®cally inhibits only proteasomal activity (Figure 2b, lane 3) . Remarkably, a RelB degradation product but not full-length RelB was found to be stabilized (Figure 2b , lanes 3 and 4) suggesting that RelB degradation occurs in at least two distinct steps: (i) an intramolecular RelB cleavage is followed by (ii) its complete degradation in the proteasome. Since the antibody used for RelB detection was raised against a C-terminal RelB peptide, the primary cut takes place near the N-terminus of RelB.
To establish a correlation between RelB phosphorylation and degradation, we performed in vitro protein kinase assays with whole protein extracts from Jurkat cells (Hibi et al., 1993) . The GST-RelB fusion proteins shown in Figure 3a (left panel) were used as substrates. Extracts from T+I or aCD3/CD28 stimulated cells led to a strong inducible phosphorylation of the Nterminal (N) and a relatively weak phosphorylation of the C-terminal RelB domain (C) (Figure 3b ). No RelB phosphorylation was detected when proteins from Jurkat cells stimulated by TNFa were used (Figure 3b , right panel). This correlates with the RelB degradation which is induced by T+I or aTCR/CD28, but not by TNFa (Figure 3b, left panel) .
To identify the phosphorylation sites within the two RelB domains we used various subfragments of these domains as substrates for in vitro phosphorylation (Figure 3a, right panel) . As shown in Figure 3c , the Nterminal peptide spanning amino acids (aa) 56 ± 102 and the C-terminal peptide of aa 524 ± 558 were found to be phosphorylated (lanes 2 and 6), while other peptides remained unphosphorylated (data not shown). Substitution of Thr84 by Ala within the N-terminal peptide (Figure 3c, lanes 3 and 4) and of Ser552 to Cys within the C-terminal peptide (lanes 7 and 8) abolished the subsequent phosphorylation demonstrating that these amino acid residues are relevant phosphoacceptors in RelB.
In order to show whether these two sites are also phosphorylated in vivo, labeling experiments were performed with EL-4 T cells which were infected with retroviral vectors expressing¯ag-tagged wild type RelB or RelB containing the two point mutations (RelB DM ). As shown in Figure 4a , only wild type RelB but not RelB DM was inducibly phosphorylated in vivo indicating that Thr84 and Ser552 are sites of inducible RelB phosphorylation in vitro and in vivo.
We also investigated whether RelB phosphorylation correlates with the degradation of RelB. To this end, the expression of RelB wild type and mutated proteins was tested after transfection. As seen in Figure 4b , two bands were detected. The faster migrating band corresponds to endogenous RelB, the slower migrating to the exogenous¯ag-tagged RelB (see Figure 4b , lanes 1 and 3). While T+I treatment led to the loss of endogenous and strong degradation of exogenous RelB (compare lane 1 with lane 2 in Figure 4b ) no degradation was found for the exogenous RelB DM protein (Figure 4b , compare lane 3 with lane 4). This shows that site-speci®c RelB phosphorylation at Thr84 and Ser552 plays an essential role in the inducible degradation of RelB.
Our study demonstrates another unique property of RelB which distinguishes RelB from other Rel/NF-kB transcription factors, i.e. its signal-induced degradation upon T cell activation. This degradation of RelB shares some features with the inducible degradation of IkBa, the best characterized inhibitor of NF-kB (Karin and Ben-Neriah, 2000) . RelB degradation is also a proteolytic process which is mediated by the proteasome and preceded by site-speci®c phosphorylations at the N-and C-termini. However, the sequence motifs surrounding the two phosphoacceptor sites in RelB dier from those in IkBa. Whereas the motifs around the two inducibly phosphorylated serine residues 32 and 36 in IkBa are recognized by the IKKs, the two RelB phosphoacceptor sites at Thr84 and Ser552 are structurally related to MAP kinase phosphorylation motifs. However, the signaling pathways leading to RelB degradation have to be elucidated in future studies.
In addition, RelB degradation diers from IkB degradation by its signal-speci®city. TNFa, a potent inducer of IkB degradation, is unable to induce RelB degradation suggesting that dierent signaling pathways are leading to RelB or IkB phosphorylation. Speci®c signaling pathways were shown to trigger the Figure 3 Signal-dependent degradation of RelB correlates with its inducible site-speci®c phosphorylation. (a) Structure of GSTRelB fusion proteins used for in vitro phosphorylation and identi®cation of phosphoacceptor sites. RHD, Rel homology domain; TAD, transactivation domain. For the construction of GST vectors, cDNAs encoding either full-length RelB or speci®c RelB domains were cloned into the EcoRI/BamHI site of either pGEX1 or 2 (AMRAD, Melbourne, Australia). The cDNAs encoded the following domains of RelB: (i) GST-RelB RHD: Rel-homology domain of RelB, amino acids (aa) 103 ± 392, (ii) GST-RelB N: Nterminal domain of RelB, aa 1 ± 102, (iii) GST-RelB C: C-terminus of RelB, aa 393 ± 558. Speci®c point mutations were introduced into RelB cDNA using the QuickChange TM site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) and the following primers: (1) aa84 (Thr4Ala): sense: 5'-CCG CCT CCG GCC GCG CCG TCC TGG AGC TGC-3'; antisense: 5'-GCA GCT CCA GGA CGG CGC GGC CGG AGG CGG-3'; (2) aa552 (Ser4Cys): sense: 5'-GGT GGC CTC CTA GCT CCA GGG CCT GAA GCC-3'; antisense: 5'-GGC TTC AGG CCC TGG AGC TAG GAG GCC ACC-3'. The GST fusion proteins were prepared as described . (b) In vitro protein kinase assays (right panel) with whole cell protein (2 mg) of unstimulated Jurkat cells (lane 1) or cells stimulated as indicated (lanes 2 ± 7) using GST-RelB fusion proteins (5 mg) as substrates were performed as described (Hibi et al., 1993) . The left panel shows RelB immunoblots of the extracts used in the kinase assays. (c) In vitro protein kinase assays with proteins from unstimulated Jurkat cells (lanes 2, 4, 6 and 8) or from cells stimulated with T+I for 30 min (lanes 1, 3, 5 and 7) using GST-RelB fusion proteins without (N2, C2) and with the point mutations Thr84Ala (N2m) and Ser552Cys (C2m) (see (a), right panel) phosphorylation and subsequent degradation of IkBa after speci®c stimulations. For example, whereas the MAP3 kinase NIK (Regnier et al., 1997) transmits signals to the IKK-signalosome(s) after TNFa-stimulation, NAK (Tojima et al., 2000) appears to be a speci®c transmitter of signals originating from aTCR/ CD28 or T+I co-stimulation. Thus, both common and speci®c signaling pathways might be involved in the inducible degradation of RelB and IkBs.
Another striking dierence between RelB and IkBa degradation is the speci®c N-terminal cleavage of RelB which is followed by its complete degradation in the 26S proteasome. The speci®c N-terminal cut generates a RelB molecule which lacks its leucine zipper a potential protein interaction domain (Ryseck et al., 1992) . Moreover, the ®rst cut leads to a loss of one of its two transactivation domains (Dobrzanski et al., 1993) . No such speci®c endonucleolytic cleavage precedes the proteasomal degradation of IkBs.
Numerous experimental data indicate that RelB acts as an activator of NF-kB-controlled transcription. However, a suppressive, inhibitory role of RelB has been observed in studies using RelB-de®cient mice (Burkly et al., 1995; Weih et al., 1995; Barton et al., 2000) . In ®broblasts from such mice, the expression of many chemokines was increased and prolonged after LPS stimulation due to enhanced NF-kB activity. This is caused by a pronounced activation of the IKKs (Xia et al., 1999) .
The regulation of NF-kB-mediated gene expression appears to be critically dependent on the equilibrium between various NF-kB species, which determines the quantitative levels and qualitative features of NF-kBdependent transcription. The signal-induced degradation of RelB, a kB factor with proven regulatory properties, certainly has a distinct impact on this equilibrium. Therefore, this process might play an important role in the regulation of NF-kB activity. 4) or RelB DM containing Thr84Ala and Ser552Cys mutations (lanes 5 and 6). The cells were incubated for 2 h in 1 ml phosphate-free medium (MEM supplemented with 0.5% dialysed FCS (Sigma)) containing 1 mCi 32 P-orthophosphate followed by stimulation with T+I for 15 min (lanes 2, 4 and 6). Immunoprecipitations were performed using ā ag-speci®c antibody (M5, Sigma) in a 1 : 100 dilution (2 ml) as described (Neumann et al., 1995) . The upper row shows an autoradiograph of the labeled RelB proteins blotted onto a nitrocellulose membrane, the lower row shows the corresponding RelB immunoblot. (b) Immunoblot with whole cell protein from uninduced Jurkat cells (lanes 1 and 3) or cells stimulated with T+I for 2 h (lanes 2 and 4) using a RelB-speci®c antibody. The cells were transiently transfected with plasmids encoding either full-length¯ag-tagged wild type RelB (WT) or RelB DM , pretreated with cycloheximide (10 mg/ml) for 20 min and activated with T+I for 2 h. The arrows indicate the positions of endogenous and¯ag-tagged exogenous RelB
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